Passion: cancer research, educating researchers, making discoveries, and turning discoveries into effective therapies for patients. #MAPK4. Opinions are my own.
“No government—regardless of which party is in power—should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.” - President Alan Garber https://t.co/6cQQpcJVTd
@raylopezfortx Again, as a PI leading a lab dedicated to cancer research, I want to focus on Science. However, removing students, postdocs, and professors due to their countries of origin (HB17) will have devastating consequences. Thank you for standing on the right side of history.
@raylopezfortx As a PI leading a lab dedicated to cancer research, I want to focus on Science. However, removing students, postdocs, and professors due to their countries of origin (HB17) will have devastating consequences. Thank you for standing on the right side of history.
🚨SB17 / HB17 would effectively ban citizens of China, Iran, North Korean + Russia from owning or leasing property in TX, unless they are US citizens or permanent residents. The bill would make it harder to recruit + retain grad students + professors. ⬇️ https://t.co/4wMSEIQ0gG
We want to focus on Science. However, removing students, postdocs, and other researchers from certain countries will have devastating consequences on scientific research. It is also clearly racist behavior no matter how people decorate it. This is insane!
🚨SB17 / HB17 would effectively ban citizens of China, Iran, North Korean + Russia from owning or leasing property in TX, unless they are US citizens or permanent residents. The bill would make it harder to recruit + retain grad students + professors. ⬇️ https://t.co/4wMSEIQ0gG
Now online in @CD_AACR: Botensilimab, an Fc-enhanced anti-CTLA-4 Antibody, Is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy - by @dhanschand and colleagues https://t.co/10gt8q7Ou4 @Agenus_Bio
🆕🗞️Just out
🪺#NEST-1 trial results👇🏾
Are we on the verge of a new drug combo for colon or rectal cancer?
Substantial & brisk responses to just☝🏾dose of BOT🟢➕BAL🔹🔹 immunotherapy.🙌🏾
Pattern & kill is unprecedented🌊.
@ASCO#GI24@OncoAlert
Abstract 117📍Poster Board H2